Our hypothesis was to demonstrate the possible pathogenic role of miltefosine in the treatment of trichinellosis through three different pathways (inflammation (GATA 3), apoptotic (caspase-3), and oxidant/antioxidant pathways (GPX1)). The gene discussed is GPX1; the disease is trichinosis.